Compared to FY2023, the group’s revenue increased by 6.3%.
Raffles Medical Group (RMG) recently released its FY2024 ended December 2024 results, which saw earnings decline by 31% y-o-y to $62.2 million, on the back of lower government grants and the absence of the fair value gain of investment properties in 2024.
On a 2HFY2024 basis, earnings gained 4.3% y-o-y to $31.6 million. Excluding fair value gain of investment properties, earnings for 2HFY2024 would have been a 38.0% y-o-y gain.
